ask="N/A"
ask_size="N/A"
average_daily_volume="968881"
bid="N/A"
bid_size="N/A"
book_value="4.05"
change="+0.00"
change_from_200_day_moving_average="-8.56"
change_from_50_day_moving_average="-6.31"
change_from_52_week_high="-17.24"
change_From_52_week_low="7.45"
change_in_percent="+0.00%"
close="38.70"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.76"
ex_dividend_date="N/A"
float_shares="85928000"
high="38.72"
high_52_weeks="55.94"
last_trade_date="12/30/2016"
last_trade_price="38.70"
last_trade_size="56133"
last_trade_time="4:00pm"
low="37.56"
low_52_weeks="31.25"
market_capitalization="3.36B"
moving_average_200_day="47.26"
moving_average_50_day="45.01"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="68.27"
open="38.01"
pe_ratio="N/A"
peg_ratio="0.63"
percent_change_from_200_day_moving_average="-18.12%"
percent_change_from_50_day_moving_average="-14.02%"
percent_change_from_52_week_high="-30.82%"
percent_change_from_52_week_low="+23.84%"
previous_close="38.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.56"
price_per_sales="224.13"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.97"
stock_exchange="NMS"
symbol="NBIX"
volume="835124"
weeks_range_52="31.25 - 55.94"
